Focus: Achieve Life Sciences is a public biotech company focused on small-molecule oncology and nephrology therapeutics, with a pipeline spanning smoking cessation, lung cancer, prostate cancer, and breast cancer indications.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Growing — net +5 jobs in 30d
9 jobs added vs 4 removed. Steady team buildout.
High-risk, high-reward play best suited for late-stage oncology specialists willing to accept restructuring uncertainty in exchange for equity upside and potential M&A event.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Achieve Life Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Achieve Life Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
+2 more
+2 more
+2 more
+2 more
8-K Filing: LISATA THERAPEUTICS, INC. (LSTA) (CIK 0000320017) — EXHIBIT 99.1
EXHIBIT 99.1
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications - GlobeNewswire
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards - GlobeNewswire
Achieve Life Sciences Announces Granting of New Hire Inducement Awards GlobeNewswire
A new finance chief received stock awards with different vesting schedules over four years. - Stock Titan
A new finance chief received stock awards with different vesting schedules over four years. Stock Titan
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates - Lelezard
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates Lelezard
Achieve Life Sciences Appoints Benjamin Halladay As CFO - Pulse 2.0
Achieve Life Sciences Appoints Benjamin Halladay As CFO Pulse 2.0
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Receptor selectivity of cytisinicline: minimal 5-HT3 binding may explain lower incidence of nausea in smoking cessation therapy.
Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
Showing 5 of 9 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo